BioCentury
ARTICLE | Top Story

SKP acquires 40.2% of RTP

August 1, 2001 7:00 AM UTC

Drug delivery play SkyePharma (LSE:SKP;SKYE) acquired a 40.2% stake in nanoparticle technology company RTP Pharma (Toronto, Ontario). SKP paid $20 million with 17.3 million SKP shares, plus $5 million...